# Recommendations for the Submission of LOINC® Codes in Regulatory Applications to the US Food and Drug Administration:  Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/recommendations-for-the-submission-of-loinc-codes-in-regulatory-applications-to-the-us-food-and-drug-administration-guidance-for-industry/ce6835ad-0bdd-4e08-b063-0e7dc3ae34d1

> FDA guidance document: Recommendations for the Submission of LOINC® Codes in Regulatory Applications to the US Food and Drug Administration:  Guidance for Industry. Issue date: November 01, 2017. Get complete insights and analysis.

---

## Details

- Title: Recommendations for the Submission of LOINC® Codes in Regulatory Applications to the US Food and Drug Administration:  Guidance for Industry
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2017-11-01
- Last Changed: 2020-04-20
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2017-D-6982">FDA-2017-D-6982</a>

## Related Documents

- [Submitting Continuous Glucose Monitoring Data in Clinical Trials](https://www.globalkeysolutions.net/guidances/guidance-document/submitting-continuous-glucose-monitoring-data-in-clinical-trials/242cfeef-dde5-46f4-b50e-9669a5a75ca9)
- [Submitting Nonclinical Datasets for Evaluation of Rodent Carcinogenicity Studies of Pharmaceuticals](https://www.globalkeysolutions.net/guidances/guidance-document/submitting-nonclinical-datasets-for-evaluation-of-rodent-carcinogenicity-studies-of-pharmaceuticals/5558f50a-6637-45c7-9848-23f5e55738d6)
- [Submitting Patient-Reported Outcome Data in Cancer Clinical Trials](https://www.globalkeysolutions.net/guidances/guidance-document/submitting-patient-reported-outcome-data-in-cancer-clinical-trials/cdd19350-5c19-44b6-9812-51398fa0fc71)